525 related articles for article (PubMed ID: 23842215)
21. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
[TBL] [Abstract][Full Text] [Related]
22. Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure.
Arora V; Vijayaraghavan R; Maiwall R; Sahney A; Thomas SS; Ali R; Jain P; Kumar G; Sarin SK
Hepatology; 2020 Sep; 72(3):1043-1055. PubMed ID: 31849085
[TBL] [Abstract][Full Text] [Related]
23. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
[TBL] [Abstract][Full Text] [Related]
24. Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia.
Vila MC; Coll S; Solà R; Andreu M; Gana J; Marquez J
Am J Gastroenterol; 1999 Aug; 94(8):2219-23. PubMed ID: 10445553
[TBL] [Abstract][Full Text] [Related]
25. Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival.
Hanafy AS; Hassaneen AM
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1455-1461. PubMed ID: 27622998
[TBL] [Abstract][Full Text] [Related]
26. In response.
Elbaz AA;
J Clin Gastroenterol; 2014 Mar; 48(3):300-1. PubMed ID: 24202000
[No Abstract] [Full Text] [Related]
27. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
Singh V; Dhungana SP; Singh B; Vijayverghia R; Nain CK; Sharma N; Bhalla A; Gupta PK
J Hepatol; 2012 Feb; 56(2):348-54. PubMed ID: 21749847
[TBL] [Abstract][Full Text] [Related]
28. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.
Fernández-Esparrach G; Guevara M; Sort P; Pardo A; Jiménez W; Ginès P; Planas R; Lebrec D; Geuvel A; Elewaut A; Adler M; Arroyo V
J Hepatol; 1997 Mar; 26(3):614-20. PubMed ID: 9075669
[TBL] [Abstract][Full Text] [Related]
29. Midodrine and albumin as a possible "winning pair" in managing paracentesis-induced circulatory dysfunction: a clinical case report.
Marigliano B; Internullo M; Scuro L; Tavanti A; Del Vecchio LR; Schito MB; Colombo GM; Guglielmelli E
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(24):9270-9274. PubMed ID: 36591858
[TBL] [Abstract][Full Text] [Related]
30. Colloids Versus Albumin in Large Volume Paracentesis to Prevent Circulatory Dysfunction: Evidence-based Case Report.
Widjaja FF; Khairan P; Kamelia T; Hasan I
Acta Med Indones; 2016 Apr; 48(2):148-55. PubMed ID: 27550886
[TBL] [Abstract][Full Text] [Related]
31. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.
Ginès A; Fernández-Esparrach G; Monescillo A; Vila C; Domènech E; Abecasis R; Angeli P; Ruiz-Del-Arbol L; Planas R; Solà R; Ginès P; Terg R; Inglada L; Vaqué P; Salerno F; Vargas V; Clemente G; Quer JC; Jiménez W; Arroyo V; Rodés J
Gastroenterology; 1996 Oct; 111(4):1002-10. PubMed ID: 8831595
[TBL] [Abstract][Full Text] [Related]
32. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
Karwa R; Woodis CB
Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
[TBL] [Abstract][Full Text] [Related]
33. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.
Ginès P; Titó L; Arroyo V; Planas R; Panés J; Viver J; Torres M; Humbert P; Rimola A; Llach J
Gastroenterology; 1988 Jun; 94(6):1493-502. PubMed ID: 3360270
[TBL] [Abstract][Full Text] [Related]
34. Large volume abdominal paracentesis effect on some humoral factors and cardiac performance in patients with liver cirrhosis and tense ascities.
El-Ashry N; El-Damarawy M; Salem M; Mogawer S
J Egypt Soc Parasitol; 2007 Aug; 37(2):571-84. PubMed ID: 17985589
[TBL] [Abstract][Full Text] [Related]
35. The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction.
Elsabaawy MM; Abdelhamid SR; Alsebaey A; Abdelsamee E; Obada MA; Salman TA; Rewisha E
Clin Mol Hepatol; 2015 Dec; 21(4):365-71. PubMed ID: 26770925
[TBL] [Abstract][Full Text] [Related]
36. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
Angeli P; Volpin R; Gerunda G; Craighero R; Roner P; Merenda R; Amodio P; Sticca A; Caregaro L; Maffei-Faccioli A; Gatta A
Hepatology; 1999 Jun; 29(6):1690-7. PubMed ID: 10347109
[TBL] [Abstract][Full Text] [Related]
37. Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements.
Schneditz D; Bachler I; Stadlbauer V; Stauber RE
Int J Clin Pract; 2008 Dec; 62(12):1851-7. PubMed ID: 17927765
[TBL] [Abstract][Full Text] [Related]
38. Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis.
Guo TT; Yang Y; Song Y; Ren Y; Liu ZX; Cheng G
J Dig Dis; 2016 Jan; 17(1):11-9. PubMed ID: 26630543
[TBL] [Abstract][Full Text] [Related]
39. Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites: a randomised pilot study.
Rai N; Singh B; Singh A; Vijayvergiya R; Sharma N; Bhalla A; Singh V
Liver Int; 2017 Mar; 37(3):406-414. PubMed ID: 27614145
[TBL] [Abstract][Full Text] [Related]
40. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
